Digi PA for Youth CF - Feasibility (V1.0)
Research type
Research Study
Full title
Feasibility randomised controlled trial of digital physical activity promotion materials for young people with Cystic Fibrosis.
IRAS ID
308638
Contact name
Samantha van Beurden
Contact email
Sponsor organisation
Royal Devon University Healthcare NHS Foundation Trust
ISRCTN Number
ISRCTN21222766
Clinicaltrials.gov Identifier
n/a, n/a
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
This is a National Institute of Health and Care Research (NIHR) Research for Patient Benefit (RFpB) funded feasibility trial of digital physical activity promotion materials (i.e., intervention) for young people living with Cystic Fibrosis (CF). CF is the most common inherited condition in the UK and is caused by a faulty gene. Physical activity (PA) is recommended in the management of CF to counter the physical and psychological effects of the condition. Despite the benefits of regular PA, it is often reported that engagement in PA is poor. PA levels among those with CF decrease during adolescence and remain low during adulthood, which can have long-term health consequences for people with CF impacting quality of life. Intervening during adolescence is therefore critical.
We have developed digital PA materials that consider unique barriers experienced by young people with CF to motivate and support engagement in PA and increase quality of life. This aim of the current study is to assess the feasibility and acceptability of these digital PA materials and of the trial procedures, in preparation for a full-scale trial which will evaluate the effectiveness of the intervention.
We aim to recruit 60 young people with CF to take part, who will be randomly assigned to receive one of two types of digital PA materials and will complete three rounds of data collection (baseline, 1-month, and 6-month follow-up). All data collection will take place online and involves: (1) answering questions about their health, PA levels, and trial satisfaction, (2) tracking their PA levels, and (3) taking part in interviews. Participants will receive their usual CF care throughout the trial.
REC name
West Midlands - Solihull Research Ethics Committee
REC reference
22/WM/0156
Date of REC Opinion
15 Sep 2022
REC opinion
Further Information Favourable Opinion